NORETHINDRONE | A076225 | DR REDDYS LABORATORIES SA
| Petition | Type | Filed | Status | Petitioner |
|---|---|---|---|---|
Suitability Petition from Rising Pharma Holdings, Inc. FDA-2026-P-3630 · 6 docket documents Rising Pharma Holdings, Inc. submitted this suitability petition pursuant to section 505(j)(2)(C) of the Federal Food, Drug, and Cosmetic Act requesting that the FDA Commissioner issue a declaration permitting submission of an Abbreviated New Drug Application for Tamsulosin Hydrochloride Capsules, U | Suitability | 2026-04-02 | Open | Rising Pharma Holdings, Inc. |
Source: Regulations.gov. FDA citizen petitions matched by application number.
Highest NADAC/Unit
$0.0943
per ea
Lowest NADAC/Unit
$0.0943
per ea
Brand NDCs
0
Generic NDCs
2
| NDC Description | NADAC/Unit | Unit | Type | Generic NADAC | Effective |
|---|---|---|---|---|---|
| 51862088603ERRIN 0.35 MG TABLET | $0.0943 | EA | Generic | — | 2026-06-17 |
| 75907007532ERRIN 0.35 MG TABLET | $0.0943 | EA | Generic | — | 2026-06-17 |
Source: NADAC (data.medicaid.gov). Prices reflect national average acquisition costs for retail community pharmacies.
No patent or exclusivity listings for this strength.